What changed in Mettler-Toledo International Inc.'s latest annual report
In the year ended 31 Dec 2025, Mettler-Toledo International Inc.'s revenue rose 4% to USD 4.03bn, from USD 3.87bn; net income rose 0.7% to USD 869.19m, from USD 863.14m; total assets rose 14.6% to USD 3.71bn, from USD 3.24bn.
Year ended 31 Dec 2025. Source: 10-K filed 6 Feb 2026, read it on SEC EDGAR.
USD 3.87bn to USD 4.03bn
The figures, year on year
| Item | Year before | Latest year | Change |
|---|---|---|---|
| Revenue | 3.87bn | 4.03bn | Up 4% |
| Net income | 863.14m | 869.19m | Up 0.7% |
| Total assets | 3.24bn | 3.71bn | Up 14.6% |
| Total liabilities | 3.37bn | 3.74bn | Up 11% |
| Long-term debt | 1.83bn | 2.09bn | Up 14% |
| Shareholders' equity | -126.89m | -23.64m | Not comparable |
Questions people ask
Did Mettler-Toledo International Inc.'s revenue grow last year?
Revenue grew 4%, from USD 3.87bn to USD 4.03bn in the year ended 31 Dec 2025.
Is Mettler-Toledo International Inc. profitable?
Yes. Net income was USD 869.19m in the year ended 31 Dec 2025. The year before: USD 863.14m.
How much cash and debt does Mettler-Toledo International Inc. have?
At its latest year end (31 Dec 2025), Mettler-Toledo International Inc. reported long-term debt of USD 2.09bn.
Where do these numbers come from?
From Mettler-Toledo International Inc.'s own annual filings with the SEC. Each change is calculated from the reported figures; nothing is estimated.
Meeting a client who works with Mettler-Toledo International Inc.?
LYNORIQ remembers every client meeting the way this page tracks a filing: what changed since last time, what you promised, and what they owe you.
Start free See the demoOther Laboratory Analytical Instruments companies
- Agilent Technologies, Inc.Cash and cash equivalents up 34.6%
- Waters CorporationCash and cash equivalents up 80.7%
- Illumina, Inc.Shareholders' equity up 14.7%
- Revvity, IncCash and cash equivalents down 20.9%
- Avantor, Inc.Cash and cash equivalents up 39.5%
- 10x Genomics, Inc.Total liabilities up 17.5%
- Bio-Rad Laboratories, Inc.Shareholders' equity up 13.5%